Effect of vitamin D treatment on magnesium levels in hemodialysis patients
Phase 3
- Conditions
- Chronic hemodialysis patients.Chronic kidney disease (CKD)
- Registration Number
- IRCT20210314050698N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age more than 18 years
Hemodialysis patients who have been on dialysis for at least three months
Vitamin D level less than 30 ng/mL
Consent to participate in the study
Exclusion Criteria
Any active or chronic infection
Magnesium supplementation
Chronic diarrhea
Hyperparathyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum magnesium level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by magnesium kit (Pars Azmoon,Iran).;Serum vitD (25-OH-VitD) level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by Vit D kit (Monobind,Iran).
- Secondary Outcome Measures
Name Time Method